{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:06:47Z","timestamp":1789132007599,"version":"build-2803163510"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jvoice.2024.11.014","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T01:57:47Z","timestamp":1732759067000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacological and Biological Relevance in the Medical Treatment of Laryngopharyngeal Reflux: A State-of-the-Art Review"],"prefix":"10.1016","author":[{"given":"J\u00e9r\u00f4me R.","family":"Lechien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2024.11.014_bib1","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lary.31134","article-title":"The dubai definition and diagnostic criteria of laryngopharyngeal reflux: the IFOS consensus","volume":"134","author":"Lechien","year":"2024","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0194599819827488","article-title":"Evaluation and management of laryngopharyngeal reflux disease: state of the art review","volume":"160","author":"Lechien","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ohn.674","article-title":"Digestive biomarkers of laryngopharyngeal reflux: a preliminary prospective controlled study","author":"Lechien","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib4","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00405-021-07201-w","article-title":"Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets","volume":"279","author":"Li","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib5","doi-asserted-by":"crossref","first-page":"E1589","DOI":"10.1002\/lary.29270","article-title":"Management of laryngopharyngeal reflux around the world: an international study","volume":"131","author":"Lechien","year":"2021","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jamaoto.2019.0315","article-title":"Surgical treatment for laryngopharyngeal reflux disease: a systematic review","volume":"145","author":"Lechien","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lary.27591","article-title":"Clinical outcomes of laryngopharyngeal reflux treatment: a systematic review and meta-analysis","volume":"129","author":"Lechien","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/coa.13395","article-title":"The management of suspected or confirmed laryngopharyngeal refluxpatients with recalcitrant symptoms: a contemporary review","volume":"44","author":"Lechien","year":"2019","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib9","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00405-021-07219-0","article-title":"Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial","volume":"279","author":"Pizzorni","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/coa.13722","article-title":"The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance-pH monitoring in patients with acid, non-acid and mixed laryngopharyngeal reflux","volume":"46","author":"Lechien","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib11","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/lary.27111","article-title":"Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease","volume":"128","author":"Tseng","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib12","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00405-018-5079-0","article-title":"Gaviscon\u00ae advance alone versus co-prescription of Gaviscon\u00ae advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux","volume":"275","author":"Wilkie","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib13","article-title":"Effectiveness of changing drug molecules in patients with refractory laryngopharyngeal reflux disease","author":"Herman","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.21053\/ceo.2019.01669","article-title":"Management of laryngopharyngeal reflux in Asia","volume":"13","author":"Kim","year":"2020","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jvoice.2013.10.020","article-title":"Efficacy of super high dose proton pump inhibitor administration in refractory laryngopharyngeal reflux: a pilot study","volume":"28","author":"Portnoy","year":"2014","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jvoice.2024.11.014_bib17","first-page":"47","article-title":"Diagnostic test with omeprazole in patients with posterior laryngitis","volume":"39","author":"Siupsinskiene","year":"2003","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jvoice.2024.11.014_bib18","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1023\/B:DDAS.0000004513.27054.d0","article-title":"Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice","volume":"48","author":"Garrigues","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvoice.2024.11.014_bib19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1097\/01.mlg.0000176547.90094.ac","article-title":"Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux","volume":"115","author":"Qadeer","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib20","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/01.MLG.0000163746.81766.45","article-title":"Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response","volume":"115","author":"Park","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mlg.0000192173.00498.ba","article-title":"Treatment of chronic posterior laryngitis with esomeprazole","volume":"116","author":"Vaezi","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10620-006-9573-7","article-title":"Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease","volume":"52","author":"Dore","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvoice.2024.11.014_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.otohns.2008.06.003","article-title":"Double-blind, placebo-controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux","volume":"139","author":"Reichel","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cgh.2010.03.009","article-title":"Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial","volume":"8","author":"Lam","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib25","first-page":"350","article-title":"Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study","volume":"40","author":"Ezzat","year":"2011","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/0194599811399240","article-title":"Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution","volume":"144","author":"Friedman","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00405-010-1475-9","article-title":"Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease","volume":"268","author":"Lee","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.anl.2011.01.010","article-title":"Do the laryngopharyngeal symptoms and signs ameliorate by empiric treatment in patients with suspected laryngopharyngeal reflux?","volume":"38","author":"Naiboglu","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2024.11.014_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12070-011-0253-3","article-title":"Clinical manifestations and role of proton pump inhibitors in the management of laryngopharyngeal reflux","volume":"63","author":"Patigaroo","year":"2011","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0892-1997(02)00115-7","article-title":"Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux","volume":"16","author":"Habermann","year":"2002","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0194599811422014","article-title":"Combination of voice therapy and antireflux therapy rapidly recovers voice-related symptoms in laryngopharyngeal reflux patients","volume":"146","author":"Park","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib32","first-page":"73","article-title":"Treatment of laryngopharyngeal reflux: a comparison between domperidone plus omeprazole and omeprazole alone","volume":"95","author":"Hunchaisri","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jvoice.2024.11.014_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/908154","article-title":"Endoscopic laryngeal findings in Japanese patients with laryngopharyngeal reflux symptoms","volume":"2012","author":"Oridate","year":"2012","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib34","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00405-012-2341-8","article-title":"The effect of itopride combined with lansoprazole in patients with laryngopharyngeal reflux disease","volume":"270","author":"Chun","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jval.2015.01.001","article-title":"Responder definition of a patient-reported outcome instrument for laryngopharyngeal reflux based on the US FDA guidance","volume":"18","author":"Lien","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jvoice.2024.11.014_bib36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1017\/S0022215113000832","article-title":"The effect of anti-reflux treatment on subjective voice measurements of patients with laryngopharyngeal reflux","volume":"127","author":"Beech","year":"2013","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jvoice.2013.12.015","article-title":"Changes in the quality of life of patients with laryngopharyngeal reflux after treatment","volume":"28","author":"Lee","year":"2014","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMENT.S13799","article-title":"Proton pump inhibitors versus solitary lifestyle modification in management of laryngopharyngeal reflux and evaluating who is at risk: scenario in a developing country","volume":"7","author":"Chappity","year":"2014","journal-title":"Clin Med Insights Ear Nose Throat"},{"key":"10.1016\/j.jvoice.2024.11.014_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jvoice.2013.12.004","article-title":"LPR: how different diagnostic tools shape the outcomes of treatment","volume":"28","author":"Wan","year":"2014","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib40","first-page":"27","volume":"63","author":"Semmanaselvan","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jvoice.2024.11.014_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jvoice.2015.12.021","article-title":"Photographic objective alterations for laryngopharyngeal reflux diagnosis","volume":"31","author":"Ozturan","year":"2017","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.amjoto.2016.01.008","article-title":"Evaluation of a laryngopharyngeal reflux management protocol","volume":"37","author":"Gupta","year":"2016","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5606\/kbbihtisas.2016.80688","article-title":"The importance of voice analysis in evaluating the effectiveness of reflux treatment","volume":"26","author":"Bat\u0131o\u011flu-Karaalt\u0131n","year":"2016","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12070-016-1046-5","article-title":"Assessment of treatment response in patients with laryngopharyngeal reflux","volume":"69","author":"Joshi","year":"2017","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/coa.13140","article-title":"Change of signs, symptoms and voice quality evaluations throughout a 3 to 6-months empirical treatment for laryngopharyngeal reflux disease","author":"Lechien","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12070-018-1493-2","article-title":"Role of proton pump inhibitors in laryngopharyngeal reflux: clinical evaluation in a North Indian population","volume":"71","author":"Bhargava","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/coa.13345","article-title":"Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study","volume":"44","author":"Yoon","year":"2019","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib48","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1055\/s-0040-1709987","article-title":"Laryngopharyngeal reflux: symptoms, signs, and presence of pepsin in Saliva - A reliable diagnostic triad","volume":"25","author":"Divakaran","year":"2021","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib49","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/coa.13737","article-title":"Peak nasal inspiratory airflow measurements for assessing laryngopharyngealreflux treatment","volume":"46","author":"Ceylan","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib50","article-title":"Laryngopharyngeal reflux disease: outcome of patients after treatment in otolaryngology clinics","volume":"12","author":"Junaid","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jvoice.2024.11.014_bib51","first-page":"29","article-title":"The effects of empiric antireflux treatment on laryngopharyngeal and gastroesophageal reflux disease","volume":"54","author":"K\u00fclek\u00e7i","year":"2020","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"10.1016\/j.jvoice.2024.11.014_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0003489420913592","article-title":"A prospective randomized clinical trial of combination therapy with proton pump inhibitors and mucolytics in patients with laryngopharyngeal reflux","volume":"129","author":"Chae","year":"2020","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.anl.2020.02.002","article-title":"Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: a prospective study","volume":"47","author":"Boom","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2024.11.014_bib54","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/01945998211026843","article-title":"24-hour multichannel intraluminal impedance-pH in proton pump inhibitor nonresponders vs responders in patients with laryngopharyngeal reflux","volume":"166","author":"Kim","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib55","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1007\/s12070-020-02323-9","article-title":"To compare and evaluate laryngeal changes in patients with dysphonia in laryngopharyngeal reflux (LPR) before and after treatment with proton pump inhibitors (PPI) and Prokinetic drugs","volume":"74","author":"Jain","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib56","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s12070-020-02005-6","article-title":"Is adjunctive alginate therapy beneficial in the treatment of laryngopharyngeal reflux disease in a rural indian population? A prospective randomized study","volume":"74","author":"Mathew","year":"2022","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib57","article-title":"Predictive value of laryngeal mucosa pepsin in therapeutic response of laryngopharyngeal reflux","volume":"S0892-1997","author":"Liu","year":"2022","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/01945998211020284","article-title":"Influence of age and sex on clinical and therapeutic features of laryngopharyngeal reflux","volume":"166","author":"Lechien","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib59","article-title":"Reliability and validity of the chinese version of reflux symptom score","volume":"S0892-1997","author":"Han","year":"2023","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21053\/ceo.2023.00409","article-title":"Predictors of early and late response to esomezol and lifestyle modification in adults with laryngopharyngeal reflux disease: a prospective, multicenter, open-label cohort study","volume":"16","author":"Kwon","year":"2023","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib61","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12070-023-03482-1","article-title":"Role of reflux symptom index and reflux finding score in diagnosing laryngopharyngeal reflux: a prospective study","volume":"75","author":"Muddaiah","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12070-022-03219-6","article-title":"Clinical evaluation of laryngopharyngeal reflux and its response to proton pump inhibitors","volume":"75","author":"Kapil","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib63","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1007\/s12070-023-03805-2","article-title":"Outpatient clinical markers for laryngopharyngeal reflux disease: a correlational study","volume":"75","author":"Paramasivam","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-024-08877-6","article-title":"Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial.","author":"Kim","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib65","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.anl.2024.02.006","article-title":"Prediction of the efficacy of proton-pump inhibitors in patients with contact granuloma using 24-hour combined dual channel pH\/impedance monitoring","volume":"51","author":"Kim","year":"2024","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2024.11.014_bib66","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12070-023-04136-y","article-title":"Reflux Symptom Index (RSI), videolaryngostroboscopy and voice analysis: a triad of non-invasive tools to study treatment outcomes of laryngopharyngeal reflux disease (LPRD)","volume":"76","author":"Suda","year":"2024","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib67","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/coa.13297","article-title":"The effect of baclofen combined with a proton pump inhibitor in patients with refractory laryngopharyngeal reflux: a prospective, open-label study in thirty-two patients","volume":"44","author":"Lee","year":"2019","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib68","first-page":"004","article-title":"Laryngopharyngeal reflux\u2013a randomized clinical controlled trial","volume":"1","author":"Pedersen","year":"2012","journal-title":"Otolaryngology"},{"key":"10.1016\/j.jvoice.2024.11.014_bib69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/lary.28736","article-title":"Hypopharyngeal-esophageal impedance-pH monitoring profiles of laryngopharyngeal reflux patients","volume":"131","author":"Lechien","year":"2021","journal-title":"Laryngoscope"},{"issue":"4 Pt 2 53","key":"10.1016\/j.jvoice.2024.11.014_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/lary.1991.101.s53.1","volume":"101","author":"Koufman","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.11.014_bib71","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1808-8694(15)31060-0","article-title":"Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: preliminary results","volume":"73","author":"Eckley","year":"2007","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib72","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0194599817709430","article-title":"Is pepsin a reliable marker of laryngopharyngeal reflux? A systematic review","volume":"157","author":"Calvo-Henr\u00edquez","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doae021","article-title":"Pilot study evaluating salivary bile acids as a diagnostic biomarker of laryngopharyngeal reflux","author":"Krause","year":"2024","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jvoice.2024.11.014_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/coa.13643","article-title":"Impact of bile acids on the severity of laryngo-pharyngeal reflux","volume":"46","author":"De Corso","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib75","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/gast.2002.36593","article-title":"Restoration of acid secretion following treatment with proton pump inhibitors","volume":"123","author":"Shin","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2024.11.014_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2036.2008.03877.x","article-title":"On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor","volume":"29","author":"Juul-Hansen","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.EBP.0000541519.81604.04","article-title":"Are proton pump inhibitors (PPIs) more effective than H2 receptor agonists (H2RAs) for adults with gastroesophageal reflux disease (GERD)?","volume":"19","author":"Callahan","year":"2016","journal-title":"Evidence-Based Practice"},{"key":"10.1016\/j.jvoice.2024.11.014_bib78","unstructured":"Centre Belge d\u2019Information Pharmacoth\u00e9rapeutique. Available at https:\/\/www.cbip.be\/fr\/. Consulted August 1."},{"key":"10.1016\/j.jvoice.2024.11.014_bib79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00228-004-0841-1","article-title":"A pharmacokinetic study comparing single and repeated oral doses of 20 and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects","volume":"60","author":"Hassan-Alin","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib80","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2125.2007.02889.x","article-title":"Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole","volume":"64","author":"Sostek","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"El Rouby","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00042737-200205000-00005","article-title":"Pharmacokinetic study of esomeprazole in patients with hepatic impairment","volume":"14","author":"Sjovall","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib83","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bcp.13615","article-title":"Safe use of proton pump inhibitors in patients with cirrhosis","volume":"84","author":"Weersink","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/ohn.878","article-title":"Minimum effective duration of laryngopharyngeal reflux disease treatment: a prospective study","author":"Lechien","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.11.014_bib85","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.2000.00856.x","article-title":"Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators","volume":"14","author":"Kahrilas","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib86","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1572-0241.2001.03600.x","article-title":"Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial","volume":"96","author":"Richter","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib87","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2005.02368.x","article-title":"A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study","volume":"21","author":"Labenz","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib88","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/000348940311200601","article-title":"Cell biology of laryngeal epithelial defenses in health and disease: further studies","volume":"112","author":"Johnston","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib89","doi-asserted-by":"crossref","DOI":"10.1159\/000400844","article-title":"Histology of the esophagus","author":"Geboes","year":"1978","journal-title":"Front Gastrointestinal Res"},{"key":"10.1016\/j.jvoice.2024.11.014_bib90","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.3748\/wjg.v21.i20.6341","article-title":"Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: a meta-analysis","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib91","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10620-022-07672-9","article-title":"Best practices in treatment of laryngopharyngeal reflux disease: a multidisciplinary modified Delphi Study","volume":"68","author":"Kamal","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvoice.2024.11.014_bib92","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1007\/s10620-017-4830-5","article-title":"Recent Advances in the pharmacological management of gastroesophageal reflux disease","volume":"62","author":"Kung","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jvoice.2024.11.014_bib93","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ajg.2013.132","article-title":"The acid pocket: a target for treatment in reflux disease?","volume":"108","author":"Kahrilas","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib94","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.13334","article-title":"Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastroin-testinal symptoms in symptomatic gastroesophageal reflux dis- ease (GERD) in China","volume":"42","author":"Sun","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib95","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.12482","article-title":"Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease","volume":"38","author":"Chiu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib96","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/coa.13518","article-title":"Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review","volume":"45","author":"Lechien","year":"2020","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib97","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","article-title":"Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use","volume":"57","author":"Maton","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jvoice.2024.11.014_bib98","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/000348940911800913","article-title":"Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells","volume":"118","author":"Johnston","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib99","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/coa.12358","article-title":"Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux\u2014a prospective comparative study","volume":"40","author":"Sereg-Bahar","year":"2015","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2036.2010.04517.x","article-title":"Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease\u2014a double-blind, placebo-controlled study","volume":"33","author":"Miwa","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.11.014_bib101","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5056\/jnm.2013.19.4.495","article-title":"Effects of the addition of mosapride to gastroesophageal reflux disease patients on proton pump inhibitor: a prospective randomized, double-blind study","volume":"19","author":"Lim","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.jvoice.2024.11.014_bib102","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/jgh.15391","article-title":"Prevalence and clinical significance of esophageal motility disorders in patients with laryngopharyngeal reflux symptoms.","volume":"36","author":"Sikavi","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.11.014_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2024.104445","article-title":"Manometric abnormalities in patients with and without chronic cough","volume":"45","author":"Watson","year":"2024","journal-title":"Am J Otolaryngol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199724003989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199724003989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:46:00Z","timestamp":1777578360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199724003989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":103,"alternative-id":["S0892199724003989"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.11.014","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological and Biological Relevance in the Medical Treatment of Laryngopharyngeal Reflux: A State-of-the-Art Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Voice Foundation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}